NCI-H2122人肺腺癌細(xì)胞
- 公司名稱 上海富雨生物科技有限公司
- 品牌
- 型號
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時間 2025/4/24 14:38:04
- 訪問次數(shù) 94
聯(lián)系方式：陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息，謝謝!
產(chǎn)品名稱：NCI-H2122人肺腺癌細(xì)胞、NCI-H2122人肺腺癌細(xì)胞、NCI-H2122人肺腺癌細(xì)胞、NCI-H2122人肺腺癌細(xì)胞；
NCI-H2122 人肺腺癌細(xì)胞
Catalogue No.: C675
Product Format: a T25 flask
Culture Properties：貼壁
Complete Growth Medium: 89%1640+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
| Item | Specifications |
| a T25 flask | 2X106 |
| Manual | 1 copy |
METHODS
Cell line, primary tumor cells and xenograft model
This study was approved by the Institutional Review Board of the Peking University School of Oncology, China. Tumor samples from a 63-year-old woman with oesophageal squamous cell carcinoma (ESCC) from Peking University Cancer Hospital were used to obtain primary tumor cells and a patient-derived xenograft (PDX) model, as previously described.11 HEK 293-FT cells, a packaging cell line used to produce high-titre lentivirus supernatants, were purchased from ATCC.
采購中心
化工儀器網(wǎng)